NASDAQ
CYduct Diagnostics, Inc. (CYDX) has a free cash flow growth of 121.56% as of Friday, May 29, 2026. This represents a 25.94% increase compared to its 12-month average of 96.52%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.